SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
17-Sep-24 5:12 PM View: | C4 Therapeutics, Inc. (CCCC) | 16-Sep-24 | Payment of Exercise | 661 | $6.36 | $4,203.96 | (< 1%) 131.37K to 130.71K | |
17-Sep-24 5:12 PM View: | C4 Therapeutics, Inc. (CCCC) | 16-Sep-24 | Option Exercise | 2,250 | -- | -- | 2% 129.12K to 131.37K | |
15-Feb-24 5:04 PM View: | C4 Therapeutics, Inc. (CCCC) | 14-Feb-24 | Grant | 27,300 | -- | -- | 27% 101.82K to 129.12K | |
15-Feb-24 5:04 PM View: | C4 Therapeutics, Inc. (CCCC) | 13-Feb-24 | Payment of Exercise | 2,255 | $6.53 | $14,725.20 | (2%) 104.08K to 101.82K | |
31-Aug-23 4:10 PM View: | C4 Therapeutics, Inc. (CCCC) | 30-Aug-23 | Payment of Exercise | 661 | $2.93 | $1,936.73 | (< 1%) 104.74K to 104.08K | |
31-Aug-23 4:10 PM View: | C4 Therapeutics, Inc. (CCCC) | 30-Aug-23 | Option Exercise | 2,250 | -- | -- | 2% 102.49K to 104.74K | |
15-Feb-23 4:46 PM View: | C4 Therapeutics, Inc. (CCCC) | 13-Feb-23 | Grant | 26,000 | -- | -- | 34% 76.49K to 102.49K | |
01-Feb-23 4:08 PM View: | C4 Therapeutics, Inc. (CCCC) | 30-Jan-23 | Payment of Exercise | 1,301 | $7.78 | $10,121.80 | (2%) 77.79K to 76.49K | |
01-Feb-23 4:08 PM View: | C4 Therapeutics, Inc. (CCCC) | 30-Jan-23 | Option Exercise | 3,750 | -- | -- | 5% 74.04K to 77.79K | |
27-May-22 4:15 PM View: | C4 Therapeutics, Inc. (CCCC) | 25-May-22 | Option Exercise | 3,750 | -- | -- | 5% 71.39K to 75.14K | |
12-Apr-22 8:41 PM View: | C4 Therapeutics, Inc. (CCCC) | 12-Apr-22 | Option Exercise | 28,084 | $4.88 | $137,120.00 | 65% 43.31K to 71.39K | |
10-Dec-21 4:30 PM View: | C4 Therapeutics, Inc. (CCCC) | 08-Dec-21 | Option Exercise | 20,562 | $3.55 | $73,000.00 | 90% 22.74K to 43.31K | |
05-Aug-21 7:34 PM View: | C4 Therapeutics, Inc. (CCCC) | 03-Aug-21 | Market Sale (Planned) | 17,057 | $45.01 | $767,812.00 | (43%) 39.8K to 22.74K | 4% |
02-Aug-21 6:46 PM View: | C4 Therapeutics, Inc. (CCCC) | 02-Aug-21 | Market Sale (Planned) | 18,104 | $45.00 | $814,756.00 | (31%) 57.91K to 39.8K | 4% |
02-Aug-21 6:46 PM View: | C4 Therapeutics, Inc. (CCCC) | 29-Jul-21 | Market Sale (Planned) | 50,211 | $45.00 | $2,259,630.00 | (46%) 108.12K to 57.91K | 4% |
04-Feb-21 4:35 PM View: | C4 Therapeutics, Inc. (CCCC) | 03-Feb-21 | Option Exercise | 8,300 | $3.25 | $26,999.40 | 8% 99.82K to 108.12K | |
04-Feb-21 4:35 PM View: | C4 Therapeutics, Inc. (CCCC) | 11-Dec-20 | Option Exercise | 14,444 | $3.18 | $45,998.40 | 17% 85.37K to 99.82K |